Top compounds associated with response to SEPT2


Feature Type Standardized
Nominal ANOVA
mRNA TW 37 GDSC1000 pan-cancer AAC 0.07 0.04
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.073 0.04
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.04
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.04
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.08 0.04
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.079 0.04
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC -0.16 0.04
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.066 0.04
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.061 0.04
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.05
Download CSV